If you are building a startup today, it’s likely harder for you to raise money than it was a year ago. New data makes it clear, however, that not every startup stage is feeling the same headwinds.
Since 2020, there has been a heightened awareness
Soma No Rx of the mental health challenges faced by learners,
Tramadol Overnight Delivery especially amid the pandemic, which forced many educational institutions to adapt to remote learning environments. Moreover, the growing interest in
Zopiclone Usa holistic and integrative approaches
Lorazepam Safe to healthcare presents an opportunity for oxygen therapy to be incorporated into a broader spectrum of pain management strategies. Understanding how these factors interact can be essential for those
Klonopin No Rx navigating the healthcare system, especially in the United States, where nuances in care and access to resources can significantly impact patient experiences. In addition, research into the effectiveness of various interventions
Buy Alprazolam No Prescription aimed at re-engaging individuals who have become apathetic is essential. In the last few years, studies
Buy Xanax Without Rx have increasingly focused on the intricate ways serotonin influences
Order Lyrica Online our sleep cycles. Companies are increasingly recognizing the importance of mental health, implementing programs to support their employees and cultivate a culture of well-being. The brain’s ability to adapt means that these
Tramadol Online Purchase physical interventions can lead to lasting changes, demonstrating the interconnectedness of body and mind. Understanding the risk-benefit
How To Buy Zolpidem Online assessment of different therapies is essential, particularly in the U.S., where healthcare approaches are continually evolving to meet the diverse needs
Tramadol No Rx of the population. It is not about eliminating anxiety
Order Valium Without Prescription altogether but
Tramadol Next Day Delivery rather learning how to manage it effectively.
A lack of uniformity in the startup fundraising climate is not novel. We have seen, variously, a Series A crunch at one point, and a Series B crunch at another. Today, however, we’re seeing something different altogether: A Series C crunch.
This does not mean that all early-stage rounds are in fine shape or that later venture rounds are healthy. Nearly everywhere you look, there are declines in venture activity that founders must contend with. But new data from Carta indicates that Series C is the current, and real, bottleneck in Venture Land, which means that this is the new crunch point for startups looking to raise their next tranche of cash.
The Exchange explores startups, markets and money.
Read it every morning on TechCrunch+ or get The Exchange newsletter every Saturday.
The data point isn’t that surprising. It’s somewhat common wisdom that the later a startup is in its maturity cycle, the more scrutiny it will be under when it seeks more money. With the IPO window closed, public-market valuations in the proverbial latrine, and crossover capital suddenly becoming scarce, late-stage startups are being vetted more like public companies today. And many of them are not ready.
Source @TechCrunch
